Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
BörsenkürzelSTVN
Name des UnternehmensStevanato Group SpA
IPO-datumJul 16, 2021
CEOStevanato (Franco)
Anzahl der mitarbeiter5521
WertpapierartOrdinary Share
GeschäftsjahresendeJul 16
AddressePiombino Dese (Pd) Via Molinella, 17
StadtPIOMBINO DESE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandItaly
Postleitzahl35017
Telefon390499318173
Websitehttps://www.stevanatogroup.com/
BörsenkürzelSTVN
IPO-datumJul 16, 2021
CEOStevanato (Franco)